USPTO serial 79306375
Serial No. 79306375
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 8, 2022
- Examiner
- BURDECKI, ANNA C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with Serial No. 79306375?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the prevention and treatment of cancer; biological preparations for medical purposes for the prevention and treatment of cancer; regenerative preparations for medical purposes, namely, regenerative cell therapy preparations being biological preparations for the prevention and treatment of cancer; cell preparations, namely, human cells for medical purposes for the treatment of diseases and disorders; stem cells for medical purposes; cells for medical use | ACTIVE | — |
| 040 | Custom processing of human cells for medical purposes for others; custom processing of therapeutic cells for medical purposes for others; custom cultivation of human cells as medical materials for others; custom cultivation of human cells for others for medical purposes; custom manufacture of pharmaceuticals; custom manufacture of biopharmaceuticals | ACTIVE | — |
| 044 | Medical services; provision of medical information; medical services relating to the removal, treatment and processing of human blood, human cells and stem cells; stem cell therapy services; medical treatment services; medical treatment services with cell preparations; medical treatment services with processed and cultivated cells; human tissue and cell bank services; analysis of human tissues and cells for medical treatment; collection, testing and preservation of human blood, human cells and stem cells for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Otsuka Pharmaceutical Co., Ltd.
- Other trademarks owned by Otsuka Pharmaceutical Co., Ltd.
- Other trademarks owned by Otsuka Pharmaceutical Co., Ltd.
- Other trademarks owned by Takara Bio Inc.
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 044
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 27, 2024 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Mar 13, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 9, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 16, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 15, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 8, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 8, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 6, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 23, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 23, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 17, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 17, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 3, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 20, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 13, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 12, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 12, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 11, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 24, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 24, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 17, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 16, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 2, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 23, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 19, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 18, 2021 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Mar 11, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |